Price
No data yet.
Social Signal Score
30
5d
30
1 mentions
—
30d
30
1 mentions
—
60d
30
1 mentions
—
90d
30
1 mentions
—
news: 1
Company Profile
- CEO
- Greg King
- Sector
- Financial Services
- Industry
- Asset Management
- Beta
- 1.71
- Country
- US
Quote
Day Range
$31.56 – $31.82
52-Week Range
$26.98 – $43.70
Volume
$15.6K
Market Cap
$116.89M
50-Day Avg
$32.24
200-Day Avg
$33.09
Prev Close
$31.40
Open
$31.69
Valuation & Ratios
P/E Ratio
—
EPS
—
P/B Ratio
—
P/S Ratio
—
Debt/Equity
—
Current Ratio
—
Dividend Yield
—
Gross Margin
—
Returns & Efficiency
Return on Equity
—
Return on Assets
—
FCF Yield
—
EV/EBITDA
—
Valuation
CEPIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80Aug 27Aug 27
Social Signal Score
30
5d
30
1 mentions
—
30d
30
1 mentions
—
60d
30
1 mentions
—
90d
30
1 mentions
—
news: 1
Mentions (1)
- Newsreuters.com·5h ago·Negative
CEPI backs Minapharm's experimental Ebola vaccine with up to $16.5 million funding The Coalition for Epidemic Preparedness Innovations will provide up to $16.5 million to Egypt-based pharmaceutical company Minapharm Group to advance an experimental Bundibugyo Ebola vaccine into human trials in Africa, the organizations said on Thursday.
View source ↗